Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients

Clin Transplant. 2018 Dec;32(12):e13436. doi: 10.1111/ctr.13436. Epub 2018 Nov 18.

Abstract

Background: We performed a study to identify differences in the urinary microbiome associated with chronic allograft dysfunction (CAD) and compared the urinary microbiome of male and female transplant recipients with CAD.

Methods: This case-control study enrolled 67 patients within the Deterioration of Kidney Allograft Function (DeKAF) Genomics cohort at two transplant centers. CAD was defined as a greater than 25% rise in serum creatinine relative to a 3 month post-transplant baseline. Urine samples from patients with and without CAD were analyzed using 16S V4 bacterial ribosomal DNA sequences.

Results: Corynebacterium was more prevalent in female and male patients with CAD compared to non-CAD female patients (P = 0.0005). A total 21 distinct Operational Taxonomic Unit (OTUs) were identified as significantly different when comparing CAD and non-CAD patients using Kruskal-Wallis (P < 0.01). A subset analysis of female patients with CAD compared to non-CAD females identified similar differentially abundant OTUs, including the genera Corynebacterium and Staphylococcus (Kruskal-Wallis; P = 0.01; P = 0.004, respectively). Male CAD vs female CAD analysis showed greater abundance of phylum Proteobacteria in males.

Conclusion: There were differences in the urinary microbiome when comparing female and male CAD patients with their female non-CAD counterparts and these differences persisted in the subset analysis limited to female patients only.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allografts
  • Bacteriuria / diagnosis
  • Bacteriuria / microbiology
  • Bacteriuria / urine*
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Graft Rejection / diagnosis
  • Graft Rejection / microbiology
  • Graft Rejection / urine*
  • Graft Survival
  • Humans
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / adverse effects*
  • Male
  • Microbiota*
  • Middle Aged
  • Postoperative Complications
  • Prognosis
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • Risk Factors
  • Transplant Recipients
  • Urine / microbiology*

Substances

  • RNA, Ribosomal, 16S